can t eat on tirzepatide What to Expect After Starting Injections What I Eat In A

Semaglutide is typically started at a low dose and increased slowly over time to give the body a chance to adjust

Semaglutide (Ozempic / Wegovy) Targets the GLP-1 receptor only Weekly subcutaneous injection Clinical trials showed average weight loss of 15-17% of body weight FDA-approved for weight management (Wegovy) and type 2 diabetes (Ozempic) Tirzepatide (Mounjaro / Zepbound) Targets both GLP-1 and GIP receptors (dual agonist) Weekly subcutaneous injection Clinical trials showed average weight loss of 20-26% of body weight the highest of any medication FDA-approved for weight management (Zepbound) and type 2 diabetes (Mounjaro) The SURMOUNT-1 trial, published in the New England Journal of Medicine, demonstrated that tirzepatide at the highest dose (15mg) produced an average weight loss of 22.5% nearly one-quarter of body weight over 72 weeks

3 Launch your customer experience Share partner links and marketing assets across social and in-person channels

However, semaglutide has a longer track record and more safety data in broader populations